Literature DB >> 12840053

Novel antibody switching defects in human patients.

John P Manis1, Frederick W Alt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12840053      PMCID： PMC162297          DOI： 10.1172/JCI19091

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  21 in total

Review 1.  Mechanism and control of class-switch recombination.

Authors:  John P Manis; Ming Tian; Frederick W Alt
Journal:  Trends Immunol       Date:  2002-01       Impact factor: 16.687

2.  AID is required to initiate Nbs1/gamma-H2AX focus formation and mutations at sites of class switching.

Authors:  Michel C Nussenzweig; André Nussenzweig; Simone Petersen; Rafael Casellas; Bernardo Reina-San-Martin; Hua Tang Chen; Michael J Difilippantonio; Patrick C Wilson; Leif Hanitsch; Arkady Celeste; Masamichi Muramatsuk; Duane R Pilch; Christophe Redon; Thomas Ried; William M Bonner; Tasuku Honjo
Journal:  Nature       Date:  2001-12-06       Impact factor: 49.962

Review 3.  Somatic hypermutation of immunoglobulin genes: merging mechanisms for genetic diversity.

Authors:  F Nina Papavasiliou; David G Schatz
Journal:  Cell       Date:  2002-04       Impact factor: 41.582

4.  Alternative end joining during switch recombination in patients with ataxia-telangiectasia.

Authors:  Qiang Pan; Corinne Petit-Frére; Aleksi Lähdesmäki; Hanna Gregorek; Krystyna H Chrzanowska; Lennart Hammarström
Journal:  Eur J Immunol       Date:  2002-05       Impact factor: 5.532

Review 5.  Molecular mechanism of class switch recombination: linkage with somatic hypermutation.

Authors:  Tasuku Honjo; Kazuo Kinoshita; Masamichi Muramatsu
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

6.  Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme.

Authors:  M Muramatsu; K Kinoshita; S Fagarasan; S Yamada; Y Shinkai; T Honjo
Journal:  Cell       Date:  2000-09-01       Impact factor: 41.582

7.  AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification.

Authors:  Svend K Petersen-Mahrt; Reuben S Harris; Michael S Neuberger
Journal:  Nature       Date:  2002-07-04       Impact factor: 49.962

8.  Transcription-targeted DNA deamination by the AID antibody diversification enzyme.

Authors:  Jayanta Chaudhuri; Ming Tian; Chan Khuong; Katrin Chua; Eric Pinaud; Frederick W Alt
Journal:  Nature       Date:  2003-04-09       Impact factor: 49.962

9.  Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2).

Authors:  P Revy; T Muto; Y Levy; F Geissmann; A Plebani; O Sanal; N Catalan; M Forveille; R Dufourcq-Labelouse; A Gennery; I Tezcan; F Ersoy; H Kayserili; A G Ugazio; N Brousse; M Muramatsu; L D Notarangelo; K Kinoshita; T Honjo; A Fischer; A Durandy
Journal:  Cell       Date:  2000-09-01       Impact factor: 41.582

10.  The function of AID in somatic mutation and class switch recombination: upstream or downstream of DNA breaks.

Authors:  Katrin F Chua; Frederick W Alt; John P Manis
Journal:  J Exp Med       Date:  2002-05-06       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.